EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence in atopic dermatitis: A narrative review

Daniel Liu, Benjamin D Hu, Jacob Glickman, Ross O'Hagan, Helen He, Emma Guttman-Yassky

Journal of Allergy and Clinical Immunology · 2025-10 · 156 (4) · 889-898

DOI: 10.1016/j.jaci.2025.06.028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-10. Verfasst von Daniel Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Artificial Intelligence. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic, inflammatory skin condition characterized by substantial clinical heterogeneity, posing significant challenges to clinicians in diagnosis, severity stratification, and management. Artificial intelligence (AI) has emerged as a transformative tool in medicine and dermatology, offering innovative solutions for disease screening, severity grading, and personalized therapeutic optimization. In AD, machine learning models have been utilized to identify novel biomarkers for therapeutic development, leading to more effective, safer, and AD-specific therapies. Additionally, these models have demonstrated the ability to diagnose AD and differentiate it from other dermatologic conditions, reducing reliance on subjective clinical assessments. Future integration of AI tools into clinical practice, such as leveraging real-time transcriptomic and proteomic data to predict optimal therapeutics, monitor treatment responses, and develop AI-embedded wearable technology for remote and continuous disease monitoring, can rapidly transform AD management. However, as technology advances, ensuring bias reduction through representative training data sets and establishing proper regulatory oversight to protect patient safety and privacy will be critical for its successful and widespread adoption. As AI continues to revolutionize AD management, its integration into clinical practice holds the potential to improve diagnostic accuracy, enhance personalized treatment approaches, and bridge health care disparities, ultimately improving human health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicArtificial IntelligenceHumansBiomarkersMachine LearningPrecision Medicine

Stichwörter der Autor:innen

Atopic dermatitisartificial intelligencebioinformaticseczemamachine learning

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: emma.guttman@mountsinai.org.

Zitieren

APA

Liu, D., Hu, B. D., Glickman, J., O'Hagan, R., He, H., & Guttman-Yassky, E. (2025). Artificial intelligence in atopic dermatitis: A narrative review. Journal of Allergy and Clinical Immunology, 156(4), 889-898. https://doi.org/10.1016/j.jaci.2025.06.028

Vancouver

Liu D, Hu BD, Glickman J, O'Hagan R, He H, Guttman-Yassky E. Artificial intelligence in atopic dermatitis: A narrative review. Journal of Allergy and Clinical Immunology. 2025;156(4):889-898. doi:10.1016/j.jaci.2025.06.028

BibTeX
@article{Liu2025,
  author = {Liu, Daniel and Hu, Benjamin D and Glickman, Jacob and O'Hagan, Ross and He, Helen and Guttman-Yassky, Emma},
  title = {Artificial intelligence in atopic dermatitis: A narrative review},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  volume = {156},
  number = {4},
  pages = {889--898},
  doi = {10.1016/j.jaci.2025.06.028}
}
Kostenlos starten →